Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO Osamu) announced that Polaris Chemicals, Inc. (Wakayama; President & CEO: TOGASHI Kazuhiko), a subsidiary established in 2021, has begun production of biocatalysts used in the production of acrylamide.
Acrylamide is a raw material for polyacrylamide, which is in turn used as a flocculant for wastewater treatment, a paper strengthening agent and a crude
oil recovery agent, among other applications.
Due to the continuous increase in global demand for acrylamide, Mitsui Chemicals' biocatalysts used in acrylamide production have gained a strong reputation among worldwide manufacturers. This has led to sales growth and the necessity to expand production capacity.
The corresponding production capacity increase will be implemented through Polaris Chemicals, Inc., a company established between Mitsui Chemicals and Kasano Kosan Corporation (Wakayama; CEO: KASANO Yasuteru).
Kasano Kosan is a customer of Mitsui Chemicals’ acrylamide, taurine and other products. The new production facilities at Polaris are set to make use of the latest technologies and expertise from Mitsui Chemicals’ Omuta Works, the company’s mother plant for these operations.
Source
